Arnuity Ellipta (fluticasone furoate)

pCPA File Number: 20884

Negotiation Status:

Concluded with an LOI

Indication(s):

Asthma

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CDA-AMC Project Number:

SR0439-000

pCPA Engagement Letter Issued:

2016-04-13

Negotiation Process Concluded:

2016-08-08